Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3336442 | Transfusion Medicine Reviews | 2016 | 8 Pages |
Abstract
Although congenital bleeding disorders can manifest in the newborn period, the most common causes of bleeding and thrombosis in neonates are acquired conditions. Factor concentrates are used for specific diagnoses (hemophilia with inhibitors, specific factor deficiency, von Willebrand disease) and approved indications, and increasingly for off-label indications (bleeding in surgery cardiopulmonary bypass, extracorporeal membrane oxygenation). We will review the approved indications for factor products in the neonate and discuss the evidence and rationale for off-label use of factor products in management of bleeding and thrombosis in the neonate.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Rowena C. Punzalan, Jerome L. Gottschall,